Xaira Therapeutics builds custom biological datasets to train specialized AI models for drug discovery. The company focuses on the thesis that advanced causal models require purpose-built causal data rather than relying solely on existing public repositories. This approach highlights the growing importance of proprietary biological data generation in accelerating computational drug development pipelines.
Opening Kapyn…